Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Oct 16, 2025; 17(10): 108729
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.108729
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.108729
Table 1 Risk groups and incidence rates, as cases per 100000 person-years
Risk groups | IRs |
HIV-positive MSM > 60 years | 107.5 |
HIV-positive MSM < 30 years | 16.8 |
HIV-positive MSM | 85 |
Non-MSM male PLHIV | 32 |
Female PLHIV | 22 |
HIV-negative MSM | 19 |
Solid organ transplant recipients | 13 |
SOTRs in males > 10 years after transplant | 24.5 |
SOTRs in females > 10 years after transplant | 49.6 |
Vulvar cancer | 48 |
Vaginal cancer | 10 |
Cervical cancer | 9 |
Systemic lupus erythematous | 10 |
Ulcerative colitis | 6 |
Crohn’s disease | 3 |
Table 2 Findings of video anoscopies of the females and males classified by 10-year age groups, n (%)
Variable | Video anoscopies (n = 16836) | ||||||||||||||||||
Male (n = 6922) | Female (n = 9914) | Total patients | |||||||||||||||||
Age group | 0-10 | 10-20 | 20-30 | 30-40 | 40-50 | 50-60 | 60-70 | > 70 | Total | 0-10 | 10-20 | 20-30 | 30-40 | 40-50 | 50-60 | 60-70 | > 70 | Total | |
Age - mean (SD) | 49.61 (14.55) | 48.11 (14.5) | 48.73 (14.54) | ||||||||||||||||
Age - median (minimum-maximum) | 50 (4-93) | 48 (5-94) | 49 (4-94) | ||||||||||||||||
Anal examination | 6 (0.09) | 117 (1.69) | 598 (8.64) | 1210 (17.48) | 1625 (23.48) | 1706 (24.65) | 1108 (16.01) | 552 (7.97) | 6922 (41.11) | 7 (0.07) | 168 (1.69) | 1071 (10.8) | 1930 (19.47) | 2336 (23.56) | 2328 (23.48) | 1447 (14.6) | 627 (6.32) | 9914 (58.89) | 16836 (100) |
Normal | 6 (100) | 77 (65.81) | 300 (50.17) | 392 (32.4) | 340 (20.92) | 260 (15.24) | 145 (13.09) | 121 (21.92) | 1641 (23.71) | 5 (71.43) | 121 (72.02) | 603 (56.3) | 781 (40.47) | 661 (28.3) | 434 (18.64) | 247 (17.07) | 136 (21.69) | 2988 (30.14) | 4629 (27.49) |
Neoplasms | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (0.18) | 2 (0.12) | 4 (0.36) | 0 (0) | 9 (0.13) | 0 (0) | 0 (0) | 1 (0.09) | 0 (0) | 3 (0.13) | 1 (0.04) | 2 (0.14) | 1 (0.16) | 8 (0.08) | 17 (0.1) |
SCC | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.06) | 1 (0.06) | 2 (0.18) | 0 (0) | 4 (0.06) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (0.09) | 1 (0.04) | 2 (0.14) | 0 (0) | 5 (0.05) | 9 (0.05) |
Adenocarcinoma | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.06) | 1 (0.06) | 1 (0.09) | 0 (0) | 3 (0.04) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.04) | 0 (0) | 0 (0) | 1 (0.16) | 2 (0.02) | 5 (0.03) |
Rare neoplasms | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.06) | 0 (0) | 1 (0.09) | 0 (0) | 2 (0.03) | 0 (0) | 0 (0) | 1 (0.09) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.01) | 3 (0.02) |
Polyps | 0 (0) | 0 (0) | 3 (0.5) | 9 (0.74) | 10 (0.62) | 10 (0.59) | 14 (1.26) | 4 (0.72) | 50 (0.72) | 0 (0) | 0 (0) | 4 (0.37) | 7 (0.36) | 14 (0.6) | 9 (0.39) | 8 (0.55) | 1 (0.16) | 43 (0.43) | 93 (0.55) |
Fibroepithelial | 0 (0) | 0 (0) | 3 (0.5) | 6 (0.5) | 10 (0.62) | 9 (0.53) | 11 (0.99) | 3 (0.54) | 42 (0.61) | 0 (0) | 0 (0) | 4 (0.37) | 7 (0.36) | 12 (0.51) | 6 (0.26) | 8 (0.55) | 1 (0.16) | 38 (0.38) | 80 (0.48) |
Hyperplastic | 0 (0) | 0 (0) | 0 (0) | 2 (0.17) | 0 (0) | 0 (0) | 2 (0.18) | 0 (0) | 4 (0.06) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.04) | 2 (0.09) | 0 (0) | 0 (0) | 3 (0.03) | 7 (0.04) |
Adenoma | 0 (0) | 0 (0) | 0 (0) | 1 (0.08) | 0 (0) | 1 (0.06) | 1 (0.09) | 1 (0.18) | 4 (0.06) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.04) | 1 (0.04) | 0 (0) | 0 (0) | 2 (0.02) | 6 (0.04) |
HPV | 0 (0) | 1 (0.85) | 10 (1.67) | 4 (0.33) | 4 (0.25) | 1 (0.06) | 1 (0.09) | 0 (0) | 21 (0.3) | 0 (0) | 1 (0.6) | 4 (0.37) | 1 (0.05) | 4 (0.17) | 2 (0.09) | 1 (0.07) | 0 (0) | 13 (0.13) | 34 (0.2) |
Perianal Crohn’s disease | 0 (0) | 3 (2.56) | 5 (0.84) | 10 (0.83) | 7 (0.43) | 1 (0.06) | 6 (0.54) | 0 (0) | 32 (0.46) | 0 (0) | 0 (0) | 4 (0.37) | 3 (0.16) | 5 (0.21) | 1 (0.04) | 2 (0.14) | 3 (0.48) | 18 (0.18) | 50 (0.3) |
Perianal fistula | 0 (0) | 1 (0.85) | 9 (1.51) | 16 (1.32) | 12 (0.74) | 10 (0.59) | 3 (0.27) | 0 (0) | 51 (0.74) | 0 (0) | 0 (0) | 2 (0.19) | 3 (0.16) | 5 (0.21) | 3 (0.13) | 0 (0) | 1 (0.16) | 14 (0.14) | 65 (0.39) |
Thrombosis hemorrhoids | 0 (0) | 6 (5.13) | 10 (1.67) | 23 (1.9) | 21 (1.29) | 16 (0.94) | 3 (0.27) | 2 (0.36) | 81 (1.17) | 0 (0) | 0 (0) | 10 (0.93) | 22 (1.14) | 17 (0.73) | 12 (0.52) | 5 (0.35) | 1 (0.16) | 67 (0.68) | 148 (0.88) |
Anal stenosis | 0 (0) | 0 (0) | 0 (0) | 1 (0.08) | 3 (0.18) | 3 (0.18) | 9 (0.81) | 4 (0.72) | 20 (0.29) | 0 (0) | 0 (0) | 1 (0.09) | 2 (0.1) | 1 (0.04) | 6 (0.26) | 4 (0.28) | 7 (1.12) | 21 (0.21) | 41 (0.24) |
Bleeding | 0 (0) | 2 (1.71) | 8 (1.34) | 28 (2.31) | 38 (2.34) | 25 (1.47) | 13 (1.17) | 7 (1.27) | 121 (1.75) | 0 (0) | 1 (0.6) | 6 (0.56) | 11 (0.57) | 10 (0.43) | 16 (0.69) | 9 (0.62) | 3 (0.48) | 56 (0.56) | 177 (1.05) |
Anal fissure | 0 (0) | 9 (7.69) | 47 (7.86) | 65 (5.37) | 50 (3.08) | 39 (2.29) | 15 (1.35) | 7 (1.27) | 232 (3.35) | 2 (28.57) | 12 (7.14) | 80 (7.47) | 80 (4.15) | 57 (2.44) | 41 (1.76) | 14 (0.97) | 4 (0.64) | 290 (2.93) | 522 (3.1) |
Hemorrhoids total | 0 (0) | 17 (14.53) | 189 (31.61) | 642 (53.06) | 1098 (67.57) | 1295 (75.91) | 866 (78.16) | 390 (70.65) | 4497 (64.97) | 0 (0) | 25 (14.88) | 327 (30.53) | 947 (49.07) | 1492 (63.87) | 1728 (74.23) | 1116 (77.13) | 453 (72.25) | 6088 (61.41) | 10585 (62.87) |
Hemorrhoids grade I | 0 (0) | 16 (13.68) | 161 (26.92) | 518 (42.81) | 793 (48.8) | 822 (48.18) | 507 (45.76) | 219 (39.67) | 3036 (43.86) | 0 (0) | 24 (14.29) | 295 (27.54) | 842 (43.63) | 1242 (53.17) | 1324 (56.87) | 828 (57.22) | 311 (49.6) | 4866 (49.08) | 7902 (46.94) |
Hemorrhoids grade II | 0 (0) | 1 (0.85) | 27 (4.52) | 119 (9.83) | 297 (18.28) | 463 (27.14) | 350 (31.59) | 165 (29.89) | 1422 (20.54) | 0 (0) | 1 (0.6) | 31 (2.89) | 103 (5.34) | 236 (10.1) | 386 (16.58) | 278 (19.21) | 133 (21.21) | 1168 (11.78) | 2590 (15.38) |
Hemorrhoids grade III | 0 (0) | 0 (0) | 1 (0.17) | 5 (0.41) | 7 (0.43) | 10 (0.59) | 9 (0.81) | 6 (1.09) | 38 (0.55) | 0 (0) | 0 (0) | 1 (0.09) | 2 (0.1) | 13 (0.56) | 18 (0.77) | 10 (0.69) | 6 (0.96) | 50 (0.5) | 88 (0.52) |
Hemorrhoids grade IV | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.06) | 0 (0) | 0 (0) | 0 (0) | 1 (0.01) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.04) | 0 (0) | 0 (0) | 3 (0.48) | 4 (0.04) | 5 (0.03) |
Others | 0 (0) | 1 (0.85) | 16 (2.68) | 22 (1.82) | 34 (2.09) | 38 (2.23) | 29 (2.62) | 15 (2.72) | 155 (2.24) | 0 (0) | 7 (4.17) | 32 (2.99) | 71 (3.68) | 61 (2.61) | 73 (3.14) | 45 (3.11) | 18 (2.87) | 307 (3.1) | 462 (2.74) |
- Citation: Gomes A, Bara J, da Matta CHKT, Paiva PP, de Carvalho LM, Bononi BM, Pinto PCC, Rodrigues JMS, Borghesi RA. Anal neoplasm in colonoscopy: What endoscopists need to know. World J Gastrointest Endosc 2025; 17(10): 108729
- URL: https://www.wjgnet.com/1948-5190/full/v17/i10/108729.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i10.108729